What is the DIR Hangover and Why Should it Keep Health System Leaders Up at Night?

Our expert, Ram Arumugam, talks to Specialty Pharmacy Times regarding the upcoming DIR fee changes for health system pharmacies.

Read time: 1 minute

By: McKesson Health Systems Editorial Team

Direct and Indirect Remuneration (DIR) Fees have been one of retail pharmacies’ biggest concerns for years – but generally, have not been widely addressed in health systems for their impact. Today, more health systems operate integrated retail pharmacies as a means of improving revenue and patient retention. To help protect those pharmacies and the patients they serve, it’s important to bring awareness to the 2023 Center for Medicare and Medicaid Services (CMS) final rule – which included language changing the definition of negotiated price for a drug.

Pharmacy Practice News and Specialty Pharmacy Times recently spoke with our expert, Ram Arumugam, to discuss what this change means for health systems with retail and specialty pharmacies and how they can address associated potential cash flow challenges.

Read the Specialty Pharmacy Times article.
Read the Pharmacy Practice News article.

Subscribe to our monthly Prescribed Perspectives newsletter to have our exclusive content delivered directly to your inbox!